AKT1 and proteostasis deficiencies: In support of this hypothesis, there is a growing body of literature that emphasizes the beneficiary effect of reduced PI3K-AKT-mTOR signaling on reducing proteotoxicity associated with protein misfolding diseases in worms and mice (Cohen et al., 2009; Morley et al., 2002).